207 related articles for article (PubMed ID: 10647621)
1. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
Trejtnar F; Laznicek M; Laznickova A; Mather SJ
J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
[TBL] [Abstract][Full Text] [Related]
2. Distribution, elimination, and renal handling of (99m)technetium-Demogastrin 1.
Trejtnar F; Laznickova A; Laznicek M; Novy Z; Maina T; Nock BA; Behe M
Cancer Biother Radiopharm; 2012 Mar; 27(2):169-74. PubMed ID: 22409267
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
4. 99mTc demotate 1: biodistribution and elimination characteristics in rats.
Kopecky M; Trejtnar F; Laznicek M; Laznickova A; Semecky V; Maina T; Nock B
Nucl Med Commun; 2005 Jun; 26(6):549-54. PubMed ID: 15891599
[TBL] [Abstract][Full Text] [Related]
5. Analysis of renal handling of radiopharmaceuticals.
Trejtnar F; Laznicek M
Q J Nucl Med; 2002 Sep; 46(3):181-94. PubMed ID: 12134135
[TBL] [Abstract][Full Text] [Related]
6. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
8. The in vivo and in vitro metabolic profile of 99mTc-NC100668, a new tracer for imaging venous thromboembolism: identification and biodistribution of the principal radiolabeled metabolite.
Edwards D; Battle M; Lear R; Farrar G; Barnett DJ; Godden V; Coombes C; Oliveira A; Ahlström H
Drug Metab Dispos; 2006 Jul; 34(7):1128-35. PubMed ID: 16611856
[TBL] [Abstract][Full Text] [Related]
9. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.
Trejtnar F; Laznicek M; Laznickova A; Kopecky M; Petrik M; Béhé M; Schmidt J; Maecke H; Maina T; Nock B
Anticancer Res; 2007; 27(2):907-12. PubMed ID: 17465219
[TBL] [Abstract][Full Text] [Related]
11. Small peptides radiolabeled with 99mTc.
Lister-James J; Moyer BR; Dean T
Q J Nucl Med; 1996 Sep; 40(3):221-33. PubMed ID: 8961801
[TBL] [Abstract][Full Text] [Related]
12. Reducing renal uptake of radiolabeled peptides using albumin fragments.
Vegt E; van Eerd JE; Eek A; Oyen WJ; Wetzels JF; de Jong M; Russel FG; Masereeuw R; Gotthardt M; Boerman OC
J Nucl Med; 2008 Sep; 49(9):1506-11. PubMed ID: 18703613
[TBL] [Abstract][Full Text] [Related]
13. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Kopecky M; Semecky V; Trejtnar F; Laznicek M; Laznickova A; Nachtigal P; Decristoforo C; Mather SJ; Mäcke HR
Nucl Med Biol; 2004 Feb; 31(2):231-9. PubMed ID: 15013489
[TBL] [Abstract][Full Text] [Related]
14. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-2GAM: a tracer for renal imaging.
Gianolli L; Dosio F; Matarrese M; Colombo F; Cutler C; Stepniak-Biniakiewicz D; Deutsch E; Savi A; Lucignani G; Fazio F
Nucl Med Biol; 1996 Nov; 23(8):927-33. PubMed ID: 9004280
[TBL] [Abstract][Full Text] [Related]
16. New bone-seeking agent: animal study of Tc-99m-incadronate.
Shigematsu M; Shomi S; Iwao H; Ochi H
Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
[TBL] [Abstract][Full Text] [Related]
17. Nc100668, a new tracer for imaging of venous thromboembolism: disposition and metabolism in rats.
Skotland T; Hustvedt SO; Oulie I; Jacobsen PB; Friisk GA; Langøy AS; Uran S; Sandosham J; Cuthbertson A; Toft KG
Drug Metab Dispos; 2006 Jan; 34(1):111-20. PubMed ID: 16251253
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the biodistribution and in vivo biochemistry of 99mTc-cysteine and 99/99mTc-cysteine complexes--a potential renal imaging agent.
Wang AY; Liu RS
Nucl Med Biol; 1995 Oct; 22(7):937-42. PubMed ID: 8547892
[TBL] [Abstract][Full Text] [Related]
19. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
Bolzati C; Cavazza-Ceccato M; Agostini S; Tokunaga S; Casara D; Bandoli G
J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
[TBL] [Abstract][Full Text] [Related]
20. A kinetic model for 99mTc-DMSA in the rat.
Maneval DC; D'Argenio DZ; Wolf W
Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
